EXASOL AG (EXL.DE) Fundamental Analysis & Valuation

FRA:EXL • DE000A0LR9G9

Current stock price

1.975 EUR
+0.02 (+0.77%)
Last:

This EXL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. EXL.DE Profitability Analysis

1.1 Basic Checks

  • In the past year EXL was profitable.
  • In the past year EXL had a positive cash flow from operations.
  • In the past 5 years EXL reported 4 times negative net income.
  • In the past 5 years EXL reported 4 times negative operating cash flow.
EXL.DE Yearly Net Income VS EBIT VS OCF VS FCFEXL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

  • EXL's Return On Assets of 7.17% is fine compared to the rest of the industry. EXL outperforms 70.69% of its industry peers.
  • Looking at the Return On Equity, with a value of 30.87%, EXL belongs to the top of the industry, outperforming 88.79% of the companies in the same industry.
  • With a Return On Invested Capital value of 3.67%, EXL perfoms like the industry average, outperforming 56.90% of the companies in the same industry.
Industry RankSector Rank
ROA 7.17%
ROE 30.87%
ROIC 3.67%
ROA(3y)-34.86%
ROA(5y)-43.4%
ROE(3y)-152.02%
ROE(5y)-136.22%
ROIC(3y)N/A
ROIC(5y)N/A
EXL.DE Yearly ROA, ROE, ROICEXL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

  • EXL's Profit Margin of 4.48% is in line compared to the rest of the industry. EXL outperforms 54.31% of its industry peers.
  • With a Operating Margin value of 3.19%, EXL perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
  • EXL has a better Gross Margin (88.94%) than 84.48% of its industry peers.
  • In the last couple of years the Gross Margin of EXL has remained more or less at the same level.
Industry RankSector Rank
OM 3.19%
PM (TTM) 4.48%
GM 88.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.92%
GM growth 5Y-0.71%
EXL.DE Yearly Profit, Operating, Gross MarginsEXL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. EXL.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXL is destroying value.
  • The number of shares outstanding for EXL remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for EXL has been increased compared to 5 years ago.
  • EXL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EXL.DE Yearly Shares OutstandingEXL.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EXL.DE Yearly Total Debt VS Total AssetsEXL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 3.28 indicates that EXL is not in any danger for bankruptcy at the moment.
  • EXL's Altman-Z score of 3.28 is fine compared to the rest of the industry. EXL outperforms 63.79% of its industry peers.
  • EXL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.28
ROIC/WACC0.49
WACC7.45%
EXL.DE Yearly LT Debt VS Equity VS FCFEXL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

  • EXL has a Current Ratio of 44.59. This indicates that EXL is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 44.59, EXL belongs to the top of the industry, outperforming 99.14% of the companies in the same industry.
  • EXL has a Quick Ratio of 44.18. This indicates that EXL is financially healthy and has no problem in meeting its short term obligations.
  • EXL has a Quick ratio of 44.18. This is amongst the best in the industry. EXL outperforms 99.14% of its industry peers.
Industry RankSector Rank
Current Ratio 44.59
Quick Ratio 44.18
EXL.DE Yearly Current Assets VS Current LiabilitesEXL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

3. EXL.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 158.81% over the past year.
  • Looking at the last year, EXL shows a quite strong growth in Revenue. The Revenue has grown by 13.18% in the last year.
  • The Revenue has been growing by 12.89% on average over the past years. This is quite good.
EPS 1Y (TTM)158.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%621.43%
Revenue 1Y (TTM)13.18%
Revenue growth 3Y13.01%
Revenue growth 5Y12.89%
Sales Q2Q%10.43%

3.2 Future

  • The Earnings Per Share is expected to grow by 159.63% on average over the next years. This is a very strong growth
  • EXL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.39% yearly.
EPS Next Y700%
EPS Next 2Y239.12%
EPS Next 3Y159.63%
EPS Next 5YN/A
Revenue Next Year6.44%
Revenue Next 2Y1.38%
Revenue Next 3Y4.31%
Revenue Next 5Y7.39%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXL.DE Yearly Revenue VS EstimatesEXL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 20M 40M 60M 80M
EXL.DE Yearly EPS VS EstimatesEXL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8 -1

6

4. EXL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 28.21, the valuation of EXL can be described as expensive.
  • 62.07% of the companies in the same industry are more expensive than EXL, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, EXL is valued at the same level.
  • The Price/Forward Earnings ratio is 17.00, which indicates a rather expensive current valuation of EXL.
  • Based on the Price/Forward Earnings ratio, EXL is valued a bit cheaper than 72.41% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.42. EXL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 28.21
Fwd PE 17
EXL.DE Price Earnings VS Forward Price EarningsEXL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EXL is valued cheaper than 81.03% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXL indicates a somewhat cheap valuation: EXL is cheaper than 60.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 25.76
EV/EBITDA 9.46
EXL.DE Per share dataEXL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as EXL's earnings are expected to grow with 159.63% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y239.12%
EPS Next 3Y159.63%

0

5. EXL.DE Dividend Analysis

5.1 Amount

  • No dividends for EXL!.
Industry RankSector Rank
Dividend Yield 0%

EXL.DE Fundamentals: All Metrics, Ratios and Statistics

EXASOL AG

FRA:EXL (3/20/2026, 7:00:00 PM)

1.975

+0.02 (+0.77%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-04
Earnings (Next)N/A
Inst Owners11.82%
Inst Owner ChangeN/A
Ins Owners3.72%
Ins Owner ChangeN/A
Market Cap53.09M
Revenue(TTM)41.66M
Net Income(TTM)1.87M
Analysts86.67
Price Target4.54 (129.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.1%
PT rev (3m)-13.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 28.21
Fwd PE 17
P/S 1.27
P/FCF 25.76
P/OCF 19.98
P/B 8.78
P/tB 10.5
EV/EBITDA 9.46
EPS(TTM)0.07
EY3.54%
EPS(NY)0.12
Fwd EY5.88%
FCF(TTM)0.08
FCFY3.88%
OCF(TTM)0.1
OCFY5%
SpS1.55
BVpS0.22
TBVpS0.19
PEG (NY)0.04
PEG (5Y)N/A
Graham Number0.6
Profitability
Industry RankSector Rank
ROA 7.17%
ROE 30.87%
ROCE 5.21%
ROIC 3.67%
ROICexc 27.93%
ROICexgc 39.64%
OM 3.19%
PM (TTM) 4.48%
GM 88.94%
FCFM 4.95%
ROA(3y)-34.86%
ROA(5y)-43.4%
ROE(3y)-152.02%
ROE(5y)-136.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.92%
GM growth 5Y-0.71%
F-Score7
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 30.72%
Cap/Sales 1.43%
Interest Coverage 265.94
Cash Conversion 81.26%
Profit Quality 110.42%
Current Ratio 44.59
Quick Ratio 44.18
Altman-Z 3.28
F-Score7
WACC7.45%
ROIC/WACC0.49
Cap/Depr(3y)7.45%
Cap/Depr(5y)49.4%
Cap/Sales(3y)0.53%
Cap/Sales(5y)5.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)158.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%621.43%
EPS Next Y700%
EPS Next 2Y239.12%
EPS Next 3Y159.63%
EPS Next 5YN/A
Revenue 1Y (TTM)13.18%
Revenue growth 3Y13.01%
Revenue growth 5Y12.89%
Sales Q2Q%10.43%
Revenue Next Year6.44%
Revenue Next 2Y1.38%
Revenue Next 3Y4.31%
Revenue Next 5Y7.39%
EBIT growth 1Y136.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3950.5%
EBIT Next 3Y268.4%
EBIT Next 5YN/A
FCF growth 1Y126.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.48%
OCF growth 3YN/A
OCF growth 5Y-9.08%

EXASOL AG / EXL.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EXASOL AG?

ChartMill assigns a fundamental rating of 5 / 10 to EXL.DE.


What is the valuation status for EXL stock?

ChartMill assigns a valuation rating of 6 / 10 to EXASOL AG (EXL.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for EXASOL AG?

EXASOL AG (EXL.DE) has a profitability rating of 4 / 10.


What is the valuation of EXASOL AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EXASOL AG (EXL.DE) is 28.21 and the Price/Book (PB) ratio is 8.78.


How financially healthy is EXASOL AG?

The financial health rating of EXASOL AG (EXL.DE) is 8 / 10.